Basic Information
ID: ALA3830152
Type: Functional
Description: Attenuation of methicillin-resistant Staphylococcus aureus USA400 MW2 virulence in BALB/c mouse systemic infection model assessed as decrease in bacterial burden in liver at 200 mg/kg, ip administered every 12 hrs for 108 hrs followed by bacterial challenge after first 12 hrs of compound dosing measured 5 days post infection
Organism: Staphylococcus aureus
Strain: MW2 USA400
Tissue: Liver
Activity Charts
Bioactivity
Activity Types for Assay ALA3830152
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 500.63 | 3.19 | 3.19 |
| 371.95 | 5.11 | 5.11 |